Metraipolis › archive › dc_8330287c17e7

Impact of V179D/E mutations on antiretroviral therapy outcomes in people living with HIV-1: a 3-year retrospective study — Europe PMC PMID:41425968

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41425968
DOI: 10.3389/fcimb.2025.1691715
License (as archived): solo-consultazione
Archived: 2026-11-07T22:11:13.824Z
SHA-256 of the archived text: 35ea08ce3cbc021c910928d782c94b910de785cdea72683d05dd4c9f8bc29571
Stable URL of this page: https://metraipolis.com/documento/dc_8330287c17e7

How to cite

Impact of V179D/E mutations on antiretroviral therapy outcomes in people living with HIV-1: a 3-year retrospective study — Europe PMC PMID:41425968 — Europe PMC (en), https://europepmc.org/article/MED/41425968 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8330287c17e7 (Metraipolis archive dc_8330287c17e7, sha256 35ea08ce3cbc021c910928d782c94b910de785cdea72683d05dd4c9f8bc29571)

BibTeX

@misc{dc8330287c17e7,
  title = {Impact of V179D/E mutations on antiretroviral therapy outcomes in people living with HIV-1: a 3-year retrospective study — Europe PMC PMID:41425968},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41425968},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8330287c17e7; sha256 35ea08ce3cbc021c910928d782c94b910de785cdea72683d05dd4c9f8bc29571},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41425968. Agents can read the archived copy with the MCP tool read_document.